Arvind Ravichandran

Ravichandran’s notable matters include representing:

• Occidental in its $57 billion acquisition of Anadarko and the pending $9.7 billion sale of OxyChem to Berkshire Hathaway;

• Shire in its $32 billion combination with Baxalta;

• Novartis in its $29.8 billion spin‑off of Alcon and its $11.4 billion spin‑off of Sandoz;
  
  
• Flowserve in its proposed $19 billion merger of equals with Chart Industries;
  
  
• Neuberger Berman in the $14.5 billion acquisition of Nord Anglia by a consortium comprising EQT, Neuberger Berman, CPP Investments and global institutional investors and in a significant investment in Mariner;
  
  
• BDT & MSD and its affiliates in connection with BDT’s combination with MSD, the formation of BDT Capital Partners Fund 4, which raised $14 billion of capital commitments, the take‑private acquisition of Weber, valuing Weber at $3.7 billion, and various private investments in excess of $3 billion;
  
  
• Aon in its $13 billion acquisition of NFP;
  
  
• Pinnacle Foods in its $10.9 billion acquisition by Conagra and its $975 million acquisition of Boulder Brands;
  
  
• Northrop Grumman in the $3.4 billion sale of its federal IT and mission support business to Veritas Capital;

• Roivant Sciences in its $3 billion Strategic Alliance with Sumitomo Dainippon Pharma;

• The special committee of the board of Eidos Therapeutics in the $2.83 billion merger with BridgeBio Pharma;

• IBM in multiple transactions, including its $2.6 billion acquisition of Truven Health Analytics, its acquisition of Resilient Systems and its acquisition of the product and technology businesses of The Weather Company;

• GreenSky in its $2.24 billion acquisition by Goldman Sachs;
• Star Bulk in its $2.1 billion combination with Eagle Bulk Shipping;

• Swvl in its $1.5 billion SPAC combination with Queen’s Gambit, including a $111.5 million PIPE investment and a $471.7 million equity financing facility;
• Alliance Laundry Systems in its $950.29 million IPO;

• GuideWell in its $900 million combination with Triple‑S Management;
• Outbrain in its $900 million acquisition of Teads;

• Lazard in its $575 million SPAC IPO;

• Eurazeo North America, as manager of funds affiliated with Eurazeo SE, in its capacity as controlling shareholder of WorldStrides and lender under the $368 million DIP facility in the pre‑packaged Chapter 11 proceedings of WorldStrides;

• Aramex in its $265 million acquisition of MyUS;

• Owl Rock in its investment in Amergin Asset Management and Fifth Season Investments’ $220 million acquisition of Fifth Season Financial and the life insurance investment assets of Chapford Capital II and Chapford Diversified Strategies Fund;
  
  
• Aras in its substantial growth investment from GI Partners;
  
  
• Barrick Gold in its joint venture with Newmont;
  
  
• Fitch Learning, a subsidiary of Hearst, in its pending acquisition of Moody’s Analytics Learning Solutions and the Canadian Securities Institute;
  
  
• Future Standard in its acquisition of the Digital Infrastructure platform of Post Road Group and its previous combination with Portfolio Advisors, creating a $75 billion alternative investment firm;
  
  
• Hayfin in the sale of Autovista to J.D. Power;
  
  
• Iris Financial, a Euronext Amsterdam‑listed SPAC sponsored by Ripplewood, in its combination with Younited;
  
  
• Martin Marietta in its pending exchange of certain assets with Quikrete;

• PG&E in various matters related to its bankruptcy and emergence, including its tri‑tranche offering, which represents the largest utility public equity offering in history;

• Proximo Spirits in its acquisition of the remaining stake in EBS, which owns Conor McGregor’s Proper No. Twelve Irish Whiskey brand;

• Unilever in the unification of its dual‑headed legal structure under a single parent company; and

• Xerox in its spin‑off of Conduent.